Every new piece of equipment carries a little bit of hope, but it’s often a lot of work to adapt to it. What works for one person doesn’t necessarily work well for another, so it takes trial and error ...

The U.S.-based nonprofit announced Eby as this year’s award winner, recognizing her wide-ranging advocacy efforts, which include raising more than $1 million for ALS research an ...

Book offers new way to share ALS experiences through letters “While many people impacted by ALS have courageously shared ...

That attitude may have served me then, but since my ALS diagnosis, I’ve had to adopt a new, more balanced way of thinking.

The ALS therapy candidate AP-101 significantly extended patient survival and delayed the need for respiratory support in a ...

A new gene therapy, Celosia's CTx1000, is now being tested for ALS in a small clinical trial in Australia. The one-time treatment targets toxic TDP-43 protein clumps, a key driver of most cases of ALS ...

ACI-19626, an experimental imaging agent developed by AC Immune, may safely detect abnormal clumps of the protein TDP-43 in ...

Eye imaging may help distinguish ALS from Alzheimer’s disease by revealing differences in retinal protein deposits using polarized light.

The funding is part of the expanding ALS Research Innovation Initiative. It’s intended to support “bold” and “imaginative” projects that could address key problems in ALS using innovative technologies ...